Market Place
Sourcing Support
Drugmakers Push FDA To Extend Support To Existing Facilities
11 Nov 2025 //
BIOSPACE
MDA And Forge Biologics Partner On AAV Development
09 Sep 2024 //
BUSINESSWIRE
Ajinomoto lay off 71 staffers in CA to CDMO business following $620M Forge buy
12 Aug 2024 //
FIERCE PHARMA
Ajinomoto To Lay Off 71 In CA After $620M Forge Biologics Acquisition
12 Aug 2024 //
FIERCE PHARMA
Forge Biologics Announces Updated Positive Clinical Data in RESKUE
11 Oct 2022 //
BUSINESSWIRE
Ray Therapeutics and Forge Biologics Expand Their Viral Vector cGMP Partnership
10 Oct 2022 //
BUSINESSWIRE
Myrtelle and Forge Biologics Form Manufacturing Partnership
07 Oct 2022 //
CONTRACTPHARMA
CNS-focused gene therapy biotech forges manufacturing deal for hearing loss drug
06 Oct 2022 //
ENDPTS
Forge Biologics to Present and Participate at Upcoming Investor Conferences
29 Sep 2022 //
BUSINESSWIRE
Forge Biologics Launch Plasmid DNA Manufacturing Services
27 Sep 2022 //
BUSINESSWIRE
Forge continues streak with $90M round for gene therapy manufacturing services
13 Sep 2022 //
ENPTS
Forge Biologics Reports Positive Clinical Data on Brain DevP & Motor Function
30 Aug 2022 //
BUSINESSWIRE
Forge Biologics to Present at Annual Jefferies Global Healthcare Conference
31 May 2022 //
BUSINESSWIRE
Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board
17 May 2022 //
BUSINESSWIRE
Forge Biologics Announces 7 Presentations at the Upcoming ASGCT
02 May 2022 //
BUSINESSWIRE
Forge Biologics to Present at Chardan’s 6th AGM and CTM Summit
14 Apr 2022 //
BUSINESSWIRE
Forge Biologics to Participate in Upcoming Investor Conferences
07 Mar 2022 //
BUSINESSWIRE
Ray Tx, Forge Biologics Enter Gene Therapy Mfg. Pact
01 Mar 2022 //
CONTRACTPHARMA
Ray Tx, Forge Biologics Announce Viral Vector Contract Development
01 Mar 2022 //
BUSINESSWIRE
Forge Biologics Closes $80M in Additional Financing for CDMO Expansion
10 Jan 2022 //
BUSINESSWIRE
Solid Biosciences,Forge Biologics Enter Development &Manufacturing Partnership
05 Oct 2021 //
CONTRACTPHARMA
Solid Biosciences and Forge Biologics Announce Partnership
04 Oct 2021 //
BUSINESSWIRE
Solid Biosciences and Forge Biologics Announce Partnership
04 Oct 2021 //
BUSINESSWIRE
Forge Biologics publishes regulatory updates from FDA and EMA
20 Sep 2021 //
BUSINESSWIRE
Forge Biologics Expands Leadership Team
31 Aug 2021 //
CONTRACT PHARMA
Forge Biologics Announces Key Hires in CDMO Operations and Medical Affairs
25 Aug 2021 //
BUSINESSWIRE
GentiBio, Forge Biologics Ink Development and Manufacturing Agreement
19 Jul 2021 //
CONTRACT PHARMA
Forge Biologics to Present at 2021 BIO Digital Conference
10 Jun 2021 //
BUSINESSWIRE
Forge Biologics Appoints John Maslowski as Chief Commercial Officer
03 Jun 2021 //
BIOSPACE
Forge Biologics to Present at the American Society of Gene Cell Therapy’s 24th
11 May 2021 //
BUSINESSWIRE
Forge Biologics Announces Closing of $120 Million Series B Financing
29 Apr 2021 //
BUSINESSWIRE
Forge Biologics bags $120M round as it looks to scale AAV manufacturing
29 Apr 2021 //
ENDPTS
Forge Biologics Receives FDA Fast Track, Orphan Drug, and Rare Pediatric Disease
16 Feb 2021 //
BIOSPACE
Forge Biologics Announces FDA Clearance of iNDA for Ph1/2 Trial of FBX-101
04 Jan 2021 //
PRNEWSWIRE
Forge Biologics Strengthens Gene Therapy Leadership with Key Hires
16 Sep 2020 //
PRNEWSWIRE
